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Introduction
Gentamicin (GM) is an aminoglycoside antibiotic widely 
used in the treatment of severe infections, caused by 
many Gram-negative and Gram-positive bacteria, such 
as meningitis, nephritis, and post-operative infections. 
Because of poor absorption following the oral admin-
istration, GM is commonly administered as injections, 
topical and ophthalmic dosage forms. The well known 
poor gastrointestinal membrane permeability and the 
consequent low bioavailability (class III of the biophar-
maceutical classification system) are likely connected 
to the high polarity of this cationic compound. Various 
approaches have been investigated in order to increase 
GM oral bioavailability, including the co-administration 
of absorption-enhancing agents such as surfactants 
(Hu et al., 2001; Ito et al., 2005), bile salts and glucos-
teroids (Axelrod et al., 1998), and liposaccharides (Ross 
et al., 2004). Although good gastrointestinal absorption-
enhancing effects were demonstrated, cytotoxicity and 
damage to the mucosa have been reported (Swenson 
et al., 1994; Aungst, 2000; Ross et al., 2004).
Another strategy aiming to promote GM oral bioavail-
ability could involve the use of microparticulate carriers. 
In fact, inert particulate matter in the micrometer range 
have been shown to be taken up by the intestinal epi-
thelia either at the level of Peyer’s patch (PP) follicle-as-
sociated epithelium (FAE) via micro-fold cells (M-cells), 
specialized cells acting over organized lymphoid tissue, 
or at the level of the mucosal epithelium through normal 
enterocytes (McClean et al., 1998; Moyes et al., 2007). In 
any case, the uptake of particulate matter appeared to be 
mainly transcellular and size-dependent (Hussain et al., 
2001; des Rieux et al., 2006).
Several studies dealing with micro- or nanoparticles 
intestinal uptake were focalized on PP and, consequently, 
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Abstract
Polysaccharide microparticles for the oral administration of gentamicin were designed in order to obtain 
an increased drug absorption by means of microparticle transport across the intestinal epithelia. Alginate/
chitosan microparticles with a size of ∼ 2 μm were developed by spray-drying a water solution contain-
ing the drug complexed with the polyanionic alginate and subsequent alginate cross-linking process by 
calcium ions and chitosan. The pre-formulation study, performed by changing the concentration of both 
cross-linkers, led to the selection of the most suitable formulation which was assayed for its capacity to be 
translocated across intestinal epithelia, via both M cells contained in Follicle Associated Epithelium (FAE) of 
Peyer’s patches and enterocytes of the mucosal epithelium. An ex vivo perfusion technique of rabbit and 
rat intestinal tissues containing Peyer’s patches combined with an in vitro method by using Caco-2 cell 
monolayers demonstrated the microparticulate carrier ability to be taken up by both M cells and entero-
cytes. However, only the endocytosis by M cells appeared to provide the microparticle transport from the 
epithelium toward deeper sub-epithelial regions.
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on drug targeting to the Gut Associated Lymphoid Tissue 
(GALT). In fact, PP contain epithelial M cells, display-
ing marked phagocytic activity, macrophages on top 
of the follicle towards the gut lumen, a dense plexus 
of lymphatic microvessels, having a porous endothe-
lium, and poor blood capillaries (Hussain et al., 2001). 
Microparticles able to be taken up selectively by FAE 
containing M cells could represent a good approach to 
achieve drug targeting into the lymph with advantages 
including avoidance of the first-pass metabolism as 
well as of the enzymatic degradation from enterocytes, 
directly delivering cytotoxic drugs in the treatment of sev-
eral pathologies spreading in the lymph system (cancers, 
HIV). Moreover, drug delivery into the lymph is an attrac-
tive way for peptides and immunostimulating molecules 
for oral vaccination (des Rieux et al., 2006). However, 
some controversial data and opinions were reported on 
the effectiveness of particle translocation across M cells. 
In fact, M cells represent a very small proportion of the 
intestinal epithelium (5% of the human FAE, i.e. ∼ 1% of 
the total intestinal surface), and the proportion differs 
widely according to the experimental animal model. 
Otherwise, more than 80% of all small intestinal epithe-
lia is occupied by enterocytes. Although they show low 
endocytic activity, there is evidence that particles can be 
translocated across enterocytes by means of macropino-
cytosis or fluid-phase pericytosis processes, delivering 
the drug into the blood circulation (Win & Feng, 2005; 
des Rieux et al., 2006).
Calcium alginate (CaA) is a natural hydrogel known 
to be suitable for the oral delivery owing to its biocom-
patibility, bioadhesiveness, resistance to the gastric 
environment, and mild gelation conditions (Stockwell 
et al., 1986; Tønnesen & Karlsen, 2002). In the CaA 
complex, the calcium ions interact mainly with oli-
gopolyguluronic sequences of the alginate, producing an 
‘egg-box’ structure (Grant et al., 1973). As alginates are 
negatively charged polymers, they form preferentially at 
the level of the mannuronic sequences complexes with 
cationic compounds (chlorpheniramine, doxorubicin, 
propranolol) (Stockwell et al., 1986; Segi et al., 1989; 
Rajaonarivony et al., 1993), as well as with polycations 
(polysaccharides, polypeptides, or synthetic polymers) 
(Bystricky et al., 1990; Thu et al., 1996; Gombotz & Wee, 
1998; Coppi et al., 2004). An alginate with high man-
nuronic content was used in a previous work to design 
a biodegradable intra-operative system releasing gen-
tamicin for bone infection treatment. The electrostatic 
interaction between the cationic gentamicin and the 
polyanion alginate led to a significant associated anti-
biotic fraction within calcium alginate implant offering a 
reservoir prolonging the release of the drug (Iannuccelli 
et al., 1996). However, the polymer network is sensitive 
to the pH, ionic strength, and ionic composition of the 
medium, swells, and disintegrates above pH 4.5 in the 
presence of calcium chelators (Gombotz & Wee, 1998; 
Takka & Acarturk, 1999). Contrary to this, complexes 
between alginate and chitosan (CS), resulting from the 
electrostatic interaction between carboxylic groups of 
alginate, for which mannuronic residues of alginate 
chains are mainly involved, with the amino group of 
CS (Lertsutthiwong et al., 2009), do not dissolve in the 
presence of calcium chelators, so they have been exten-
sively used to stabilize the gel in media simulating the 
intestinal environment and to reduce the porosity of 
the Ca-alginate network (Thu et al., 1996; Gombotz & 
Wee, 1998; Takka & Acarturk, 1999). Moreover, CS has 
received considerable attention for its biocompatibility, 
mucoadhesiveness, and intestinal permeation enhanc-
ing properties for the paracellular route (Felt et al., 1998; 
Sinha et al., 2004). The permeation enhancing prop-
erty of CS was suggested to involve a combination of 
mucoadhesion, by increasing the contact time with the 
mucosa, and of a transient opening of epithelial cell tight 
junctions (Silva et al., 2006), even if this hypothesis was 
ruled out for chitosan nanoparticles likely transported by 
adsorptive endocytosis (des Rieux et al., 2006).
Therefore, CaA/CS microparticles for the improvement 
of GM oral absorption were obtained by spray-drying 
technique and cross-linking procedures. The current 
paper involved, at first, a pre-formulation study focusing 
on the influence of the cross-linkers on microparticle 
morphological and dimensional properties, GM loading 
level, and release behavior in simulated gastrointestinal 
(GI) media. Then, a selected microparticle formulation 
was investigated for its suitability to be transported 
across either FAE via M cells or mucosal epithelium via 
enterocytes. An ex vivo model based on perfused rabbit 
and rat intestinal tissues was performed and combined 
with interferential and confocal microscopy to detect 
microparticle bioadhesion and translocation by M cells 
at Peyer’s patches, whereas an in vitro model by means of 
Caco-2 cell lines was adopted to evaluate microparticle 
uptake by enterocytes.
Materials and methods
Materials
Gentamicin sulfate (GM), chitosan (CS) (low Mw ∼ 70,000, 
acetylation degree ∼ 85–90%), and fluorescein isothiocy-
anate (FITC) were purchased from Fluka Chemie (Buchs, 
Switzerland). O-Phthaldialdehyde (OPA) was purchased 
from Sigma-Aldrich (Milan, Italy). Sodium alginate (NaA) 
(Mw ≅ 147,000), containing 62% mannuronic acid and 
38% guluronic acid, was kindly donated by ISP Alginates 
(Girvan, UK). Culture reagents for intestinal Caco-2 cell 
lines were purchased from Euroclone-Celbio (Milan, 
Italy) and Hoechst 33258 stain from Hoeschst (Frankfurt, 
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28  V. Iannuccelli et al.
Germany). All the other chemicals were of analytical 
grade.
Microparticle preparation
Un-cross-linked microparticles were obtained by 
spray-drying (Buechi 190 Mini Spray-Dryer, Buechi 
Laboratoriums, Technik AG, Flavil, Switzerland) a 1.0% 
(w/v) NaA water solution containing GM (NaA/GM 
ratio = 10/1) under the following operating conditions: 
inlet temperature 140°C, outlet temperature 60°C, pump 
setting 15 ml/min, spray flow 500 Nlh−1, aspirator setting 
10, and nozzle cup diameter 0.5 mm. Polymer and drug 
concentrations were chosen to obtain solutions with low 
viscosity and to avoid the precipitation of the insoluble 
alginate/GM complex.
Cross-linked microparticles were obtained by pour-
ing 250 mg un-cross-linked microparticles into 25 ml 
aqueous calcium chloride solution at different con-
centrations (1.0, 1.5, and 2.5% w/v) under stirring at 
8000 rpm by means of an Ultra-Turrax homogeniser 
(Ultra-Turrax, IKA, Labortechnik, Staufen, Germany) 
for 10 min.
Co-cross-linked microparticles have been prepared by 
stabilizing the cross-linked microparticles obtained with 
1.0% calcium chloride solution by the treatment with a 
pH 5.2 acetic acid solution of CS (25 ml) at different con-
centrations (0.5, 1.0, and 2.0%) for 10 min.
Both the cross-linked and co-cross-linked micropar-
ticles were recovered by centrifugation (4000 rpm for 
10 min), rinsed with distilled water, collected by centrifu-
gation, and freeze-dried (Lyovac GT2, Leybold-Heraues 
GMBH, Köln, Germany). Microparticle formulation vari-
ables are listed in Table 1.
The formulation A1 was selected to prepare a fluo-
rescent sample (A1F) to be used in the microparticle 
translocation studies. The sample A1F was prepared by 
incubating overnight a 100/1 water/acetone solution of 
1/0.01 GM/FITC. The GM/FITC conjugate solution, mixed 
with NaA water solution in a 10/1/0.01 NaA/GM/FITC 
ratio, was spray-dried as described above. The obtained 
FITC-labeled microparticles were cross-linked with 1.0% 
CaCl
2
 and co-cross-linked with 0.5% CS according to the 
same technique described above.
Morphological and dimensional analysis
Morphological and dimensional analyses were performed 
using scanning electron microscopy (SEM, XL-40 Philips, 
Eindhoven, The Netherlands). Microparticle samples 
were placed on the aluminum stub using double-side 
adhesive tape, coated with a thin film of gold-palladium, 
and imaged at 8 kV.
Microparticle size and size distribution were deter-
mined by analyzing SEM photomicrographs by image 
processing software (IMG-VIEW, CIGS, University of 
Modena and Reggio Emila). All analyses were performed 
on at least 100 microparticles from different batches.
Calcium content determination
Calcium content was determined by suspending exactly 
weighted microparticle samples in water or dissolving 
them in 3% (w/v) sodium citrate aqueous solution acting 
as calcium ions chelating agent. After 24 h, the filtered 
solutions were analyzed by flame atomic absorption 
spectroscopy using a model 3030 spectrophotometer 
(Perkin-Elmer). The calibration graph was obtained by 
standard solutions ranging from 1–5 mg Ca2+/l.
The calcium values obtained by the sample solutions 
and suspensions represent the total calcium amount and 
the free (non-associated to alginate) calcium amount, 
respectively. The differences between these values were 
considered as the fraction associated to alginate. All data 
were averaged on three determinations.
EDX analysis
Microparticle samples, soaked in water for 24 h to remove 
the free calcium and dried, were analyzed for calcium 
X-ray emission by EDX (EDAX 9900, Edax International, 
Prairie View, IL) coupled to SEM. The peak intensities 
of Ca (3.69 keV) and Na (1.04 keV) were obtained with 
the following experimental settings: accelerating volt-
age 12 kV, detection limit ∼ 0.3%, and spatial resolution 
0.1 μm. The reported data represent the average of six 
points detected on three images for each sample.
GM content determination
GM content was determined by suspending exactly 
weighted microparticle samples in water or dissolving 
them in 3% (w/v) sodium citrate aqueous solution displac-
ing the drug associated to alginate. After 24 h, ∼ 2 ml were 
removed and centrifuged by using an ultrafiltration con-
centrator with a regenerated cellulose membrane (2 ml, 
MWCO 30,000 RC, Vivaspin, Vivascience AG, Hannover, 
Table 1. Formulation variables and dimensional properties of the 
microparticles.
Microparticles
Sample 
code
CaCl
2
  
(%, w/v)
CS 
(%, w/v)
Mean size ± 
SD (μm)
Un-cross-linked U 0 0 3.47 ± 1.36
Crosslinked A 1.0 0 2.95 ± 0.88
B 1.5 0 2.92 ± 1.09
C 2.0 0 2.41 ± 0.59
Co-cross-linked A1 1.0 0.5 2.30 ± 1.02
A2 1.0 1.0 1.89 ± 0.79
A3 1.0 2.0 2.31 ± 0.89
Fluorescent A1F 1.0 0.5 2.16 ± 0.67
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Germany) in order to remove alginate. The concentra-
tion of GM derivatized by reaction with OPA (Al-Amoud 
et al., 2002) was determined on an aliquot of 1 ml from 
the filtered solution by reversed-phase high perform-
ance liquid chromatography (HPLC). Chromatography 
was performed by an Agilent Technologies (Waldbronn, 
Germany) modular model 1100 system consisting of a 
vacuum degasser, a quaternary pump, an autosampler, a 
thermostatted column compartment, and variable wave-
length detector. A Lichrospher RP-18 column (125 × 4 mm 
I.D., 5 μm, Agilent Technologies), with a Lichrospher 
RP-18 guard column (4 × 4 mm I.D., 5 μm, Agilent 
Technologies) was used at room temperature with a flow 
rate of 0.6 ml/min and a total running time of 12 min. The 
mobile phase consisted of methanol, glacial acetic acid, 
and water (800/20/180), containing 0.02 M sodium hep-
tanesulfonic acid (pH 3.4). The detector monitored the 
eluent at 340 nm. Three injection volumes of 50 μl were 
used for each sample. Peaks were identified on the basis 
of their retention time values and UV spectra by com-
parison with that of the standard solution of GM-OPA 
derivative. Peak identity was also confirmed by spiking 
the samples with the pure standard (standard addition 
method). Quantification was performed by four-point 
external standard calibration, by plotting the peak area 
of the GM-OPA derivative solution at each level prepared 
vs the corresponding concentration.
GM fraction obtained by water extraction was con-
sidered as non-associated drug, whereas that obtained 
by dissolving the samples in sodium citrate solution as 
the total drug. The differences between these values were 
considered as the drug fraction associated to alginate. The 
percentage encapsulation efficiency (EE) was calculated 
by relating the practical drug entrapment to the theoreti-
cal one (9.09% w/w). The reported data were averaged on 
at least three determinations.
GM antimicrobial activity determination on 
microparticles
A microbiological agar well diffusion method was per-
formed (Giamarellou et al., 1975) on un-cross-linked 
(sample U), cross-linked (sample A), and co-cross-linked 
(sample A1) microparticles in order to investigate whether 
GM activity was maintained throughout the manufacture 
steps. Tryptic soy agar (15 ml) and Bacillus subtilis strain 
ATCC 6633 (105 CFU/ml) were used as growth medium 
and indicator micro-organism, respectively. The wells in 
agar plates were filled with microparticle solution (100 
μl) obtained by dissolving an exactly weighted micropar-
ticle sample in 3% (w/v) sodium citrate aqueous solution 
and with standards of free GM in 3% (w/v) sodium citrate 
aqueous solution (100, 40, 20, 10, 4 μg/ml) in the same 
plate for each sample. The glass plates were incubated 
at 37°C overnight and the growth of bacteria colonies 
was monitored. Inhibition zone diameters produced 
by the microparticle samples containing a known GM 
amount were plotted on the calibration curve obtained 
by relating the zone inhibition diameter to GM concen-
tration of standard solutions. The analyses were made in 
triplicate.
In vitro drug release study
The release of GM from cross-linked and co-cross-linked 
microparticles was carried out, under sink conditions and 
at 37°C, in HCl water solution at pH 3.0, which could be 
well-representative of a gastric average pH value, for the 
first 2 h and, subsequently, in 0.5 M Tris-HCl buffer solu-
tion at pH 7.4 for 3 h, simulating an intestinal pH medium 
not containing calcium binding ions.
A weighted amount of microparticles (100 mg) was 
suspended in a glass bottle containing 50 ml of the release 
media under stirring at 100 rpm. At fixed time intervals, 
2 ml of solution were withdrawn, centrifuged at 4000 rpm 
for 10 min by using a centrifugal concentrator (MWCO 
30,000 RC) and analyzed by reversed-phase HPLC after 
derivatization with OPA as described above. An equal 
volume of the same dissolution medium was replaced 
to maintain a constant volume. The experiments were 
performed in triplicate.
Fluorescence detection
Sample A1F was examined for FITC content by placing 
exactly weighted amounts of microparticles in 3% w/v 
sodium citrate aqueous solution. After centrifugation, 
FITC concentrations in supernatant were assayed spectro-
photometrically (λ = 488 nm) (Lambda 35, Perkin-Elmer, 
Norwalk, CT). Microparticle capacity to maintain the 
fluorescence was evaluated on the sample A1F, exposed 
to the same conditions as those of the release assay, by 
optical videomicroscope coupled with epifluorescence 
using a FITC filter (N-400FL, Optika Microscopes, MAD 
Apparecchiature Scientifiche, Bergamo, Italy).
Evaluation of microparticle bioadhesion and uptake 
by M cells
An ex vivo study was performed on intestinal tracts of 
rabbits and rats containing Peyer’s patches which are 
easily observable as elongated or round thickenings of 
the intestinal epithelium measuring ∼ 1 cm in length. 
Tracts of the small intestine were excised from just sacri-
ficed adult rabbits (white New Zealand, ∼ 2.5 kg) and rats 
(Sprague Dawley, ∼ 0.2 kg) in accordance with procedures 
adhering to the European Community Regulations (CEE 
Council 89/609) and maintained in oxygenated Tyrode at 
37°C. The intestinal content was drained out, the lumen 
was cleaned with physiological solution, and the intestine 
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was dissected to give 15 cm segments containing 4 or 5 
PP, placed in oxygenated Tyrode at 37°C, connected with 
a peristaltic pump and perfused with a water suspension 
of the sample A1 and A1F (50 mg/25 ml) for rabbit and 
rat tissue, respectively, at the flow rate of 1 ml/min. After 
30 min, microparticle suspension was removed, and the 
perfused tissue was longitudinally cut and washed with 
physiological solution.
For the mucoadhesion and uptake studies in rabbits, 
the Bouin’s-fixed gut, dehydrated with a progressive 
ethanol series, embedded within paraffin, was sectioned 
using a cryomicrotome (HM 500 OM, Micron, Walsdorf, 
Germany) giving ∼ 7 μm thick sections and viewed by 
interferential microscope (Axiophot, Zeiss, Oberkochen, 
Germany).
For the mucoadhesion study in rats, the intesti-
nal segments were directly observed by fluorescence 
microscopy (DM IRE2, Leica Microsystems Heidelberg 
GmbH, Mannheim, Germany). For the M cell uptake, 
the segments were fixed in paraformaldehyde (3% w/v) 
for 2 h, embedded in cryostatic medium, sliced in 12 μm 
thick sections at −20°C by using a microtome cryostat 
(HM 500 O, Microm International GmbH, Walldorf, 
Germany), and viewed by fluorescence microscopy and 
confocal laser scanning microscopy (DM IRE2, Leica 
Microsystems Heidelberg GmbH) at 1.1 μm step. To 
examine the actual antibiotic translocation inside the PP 
and the role of the microparticles on the GM transloca-
tion, the rat perfused intestinal segments were evaluated 
by microbiological activity in comparison with untreated 
intestinal tissue from the same rat as well as with intes-
tinal tissues perfused with microparticles suspended in 
pH 7.4 phosphate buffer solution at the same conditions 
described above. Two isolated PP and equivalent non-PP 
tissue were homogenated by a glass Potter homogenizer 
in 3% w/v sodium citrate aqueous solution (5 ml). After 
centrifugation, the supernatant was discarded and 
analyzed for microbiological activity according to the 
method described above for GM antimicrobial activity 
determination on microparticles.
Evaluation of microparticle uptake by Caco-2 cells
Caco-2 cells, deriving from human colonic adenocarci-
noma and producing confluent monolayers of enterocyte-
like cells, were cultured at 37°C in Dulbecco’s Modified 
Eagle’s Minimal Essential Medium (DMEM) with 10% 
Fetal Bovine Serum (FBS) and 1% non-essential aminoac-
ids. Cells were seeded 48 h before the incubation with the 
microparticle suspension. The sample A1F, suspended in 
water (10 mg/5 ml) and diluted 1:1 in DMEM, was applied 
to the cell monolayer and then incubated at either 37°C 
for 3 h and 6 h or 4°C for 6 h. Cells were washed twice 
with Phosphate Buffer Saline (PBS) and then collected by 
trypsinization for the cytometry analysis. Flow-cytometry 
evaluation of intracellular uptake was performed by a 
Coulter Epics XL flow cytometer equipped with a 488 nm 
argon laser. FITC fluorescent cells were expressed as a 
percentage of the total cell population. Moreover, after 
6 h of incubation at 37°C with the microparticles, the 
Caco-2 cells were fixed in paraformaldehyde (3%, w/v) 
for 15 min at room temperature, washed in PBS, and 
observed under filter set for both green and blue fluores-
cence by using confocal laser scanning microscopy (DM 
IRE2, Leica Microsystems, Heidelberg GMbH) at 1.1 μm 
step after cell nucleus staining by Hoechst 33258 stain 
(blue) (2 μg/ml) for 20 min at room temperature. To verify 
the behavior of FITC alone, FITC solutions in DMEM at 
the concentration corresponding to that present in the 
sample A1F (0.6 μg/ml) were incubated with Caco-2 cells 
at the same conditions used for the microparticles. The 
experiments were performed in triplicate.
Statistical analysis
Statistical analysis was performed by using one-way 
analysis of variance (ANOVA). Significance was indicated 
by p < 0.05.
Results and discussion
Pre-formulation study
Cross-linked and co-cross-linked alginate microparticles 
loaded with GM were developed by spray-drying tech-
nique and cross-linking by calcium ions and calcium 
ions/CS, respectively. Co-cross-linked microparticles 
were obtained by treating with CS the sample A selected 
among the cross-linked microparticles due to its higher 
drug encapsulation efficiency (Table 2).
Dimensional and morphological analysis
Morphological analysis by SEM showed distinct and well 
formed un-cross-linked microparticles (sample U) having 
a nearly spherical shape and smooth surface (Figure 1a). 
Table 2. Calcium and GM content in microparticle samples.
Sample
Total  
calcium  
(%, w/w)
Associated  
calcium  
(%, w/w)
GM  
content  
(%, w/w)
GM encap-
sulation 
efficiency (%)
U — — 8.47 ± 0.69 93.18 ± 7.70
A 9.15 ± 0.12 9.00 ± 0.10 5.94 ± 0.62 65.34 ± 12.50
B 10.65 ± 0.71 9.88 ± 0.57 3.08 ± 0.21 33.88 ± 2.27
C 13.97 ± 0.57 12.69 ± 0.45 2.17 ± 0.51 23.87 ± 5.65
A1 8.03 ± 0.47 7.62 ± 0.50 5.55 ± 0.41 61.06 ± 4.58
A2 7.80 ± 0.27 7.41 ± 0.29 5.68 ± 1.17 62.49 ± 6.92
A3 5.80 ± 0.31 5.39 ± 0.34 5.60 ± 0.91 61.61 ± 10.55
A1F 8.21 ± 0.67 7.68 ± 0.49 5.42 ± 0.40 59.63 ± 4.45
Values represent the mean ± SD.
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Both the cross-linking processes didn’t modify substan-
tially microparticle morphology with the exception of the 
sample A3 containing aggregates and irregular shaped 
particles (Figures 1b–d).
The mean size of the cross-linked and co-cross-linked 
microparticles was ∼ 2 μm (Table 1), with the most popu-
lation (70–80%) less than 3 μm (Figure 2). No significant 
difference (p > 0.05) in the mean size was found between 
the samples and the batches. The size of particulate mat-
ter is considered a critical parameter affecting greatly 
the translocation process across the intestinal epithelia. 
Although some discordant results, in general particles 
with a size up to 2 μm, have been reported to be taken 
up by enterocytes (Snoeck et al., 2005), and particle sizes 
less than 3 μm are preferable to be taken up by M cells 
because particles in the range of 3–10 μm are retained in 
PP and do not migrate into the mesentheric lymph nodes 
(Florence, 1997).
Evaluation of calcium and chitosan complexation 
with alginate
To evaluate alginate cross-linking degree according to the 
formulation parameters, the content of calcium associ-
ated to the polyanionic alginate was determined by flame 
atomic absorption spectroscopy (Table 2). The calcium 
associated to the polymer increased with increasing 
CaCl
2
 concentration used in the preparation (p < 0.05) 
overcoming in all the samples the theoretical associa-
tion value (1.1 mol/g polymer, corresponding to ∼ 4.2% 
calcium), calculated in a previous work for a complete 
neutralization of the guluronic blocks by calcium ions in 
a 1:2 calcium/uronic acid molar ratio (Iannuccelli et al., 
1996; Morris et al., 1978). Such an overcoming confirms 
the calcium ability to interact also with alginate man-
nuronic sequences. The cross-linking reaction by calcium 
would occur quite homogeneously among the micropar-
ticles in all the samples, as revealed by the quite similar 
values of calcium X-ray emission intensity from distinct 
microparticles (Figure 3). The addition of CS as a sec-
ondary cross-linker provided a slight even if significant 
(p < 0.05) decrease in the associated calcium amount only 
in the sample A3. Since calcium ions bind the guluronic 
sequences strongly, in a highly cooperative way, a com-
petition on the same carboxylic groups between calcium, 
weakly bound to alginate mannuronic residues, and the 
polycation CS at this highest concentration could be 
hypothesized. In any case, CS should be, presumably, 
localized in the outer layer of the microparticles owing 
to its low diffusivity through the alginate network, as 
reported by others (Tønnesen & Karlsen, 2002; Sarmento 
et al., 2007; Wittaya-Areekul et al., 2006).
Statistical analysis showed no significant difference 
(p > 0.05) in calcium content between the batches.
Evaluation of GM content and complexation with 
alginate
Gentamicin is a cationic drug able to interact selec-
tively with the mannuronic residues of the polyanionic 
alginate, as previously reported (Iannuccelli et al., 
1996). Such an interaction could be potentially useful 
to improve the encapsulation efficiency of hydrophilic 
cationic drugs and to prevent the drug leaching into 
the gastrointestinal tract before the microparticle 
uptake by the intestinal epithelia. Table 2 shows GM 
content values obtained by dissolving the samples in 
a sodium citrate solution containing drug binding ani-
ons. Since no drug fraction was extracted by water, the 
drug loaded in every sample could be considered as 
complexed with alginate. GM content in the un-cross-
A
10 µm
B
10 µm
C
10 µm
D
10 µm
Figure 1. SEM images of un-cross-linked (sample U) (a), cross-linked 
(sample A) (b), co-cross-linked (sample A1) (c), and co-cross-linked 
(sample A3) (d) microparticles.
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Figure 2. Size distribution of un-cross-linked (sample U), cross-linked 
(sample A), and co-cross-linked (sample A1) microparticles.
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linked microparticles (EE = 93.18 ± 7.6%) corresponds 
to the association capacity of the drug on alginate (0.08 
mmoles of gentamicin per gram of polymer, correspond-
ing to ∼ 5.4% gentamicin), as demonstrated in a previous 
work (Iannuccelli et al., 1996). The cross-linking process 
by calcium ions reduced the amount of GM associated 
to the polymer and GM loading levels decreased pro-
gressively with the increase of calcium concentration 
(p < 0.05). These results indicate a competitive interac-
tion of GM and calcium for the same carboxylic acid 
sites on alginate M blocks, confirming that calcium can 
also interact with the polymannuronic sequences. On 
the contrary, GM content in co-cross-linked micropar-
ticles was not affected by CS concentration (p > 0.05), 
suggesting the inability of the polycation to displace GM 
from alginate M residues. Statistical analysis showed no 
significant difference (p > 0.05) in drug loading levels 
between the batches.
Evaluation of GM antimicrobial activity
A microbiological assay was performed on un-cross-
linked, cross-linked, and co-cross-linked microparticle 
samples in order to study the effect of the prepara-
tion steps on GM antibiotic activity. By comparing the 
inhibition zone provided by the microparticle samples 
with that produced by a standard solution of the drug, 
all the samples produced inhibition zone diameters 
corresponding to the own GM loading value, provid-
ing evidence of GM activity preservation during both 
spray-drying (sample U) and cross-linking procedures 
(samples A and A1) (Figure 4). In fact, statistical analysis 
showed no significant difference (p > 0.05) in the inhibi-
tion diameters between the batches.
In vitro drug release study
Since sodium alginate is water-soluble in its un-cross-
linked state, GM release study was performed on cross-
linked and co-cross-linked microparticles capable of 
maintaining their integrity in aqueous media, which is 
an essential requisite for microparticle transport across 
intestinal epithelia. GM in vitro release from cross-linked 
and co-cross-linked microparticles was evaluated in a pH 
3.0 medium for 2 h and, then, in pH 7.4 Tris-HCl buffer for 
4 h in order to simulate the pH conditions of the gastroin-
testinal tract (Figure 5). By considering that phosphate 
buffer species, having a chelating action on calcium, are 
disconnected with the principal physiological species in 
the human GI tract (Dressman & Reppas, 2000; Sheng 
et al., 2009), Tris-HCl buffer was selected instead of phos-
phate buffer. The cross-linked microparticles provided a 
three-phase profile showing a negligible GM release at 
pH 3.0 and a burst effect (∼ 60%) followed by a gradual 
release phase at pH 7.4. This behavior is in agreement 
with previously reported data (Mumper et al., 1994) where 
it is assumed that, upon acid treatment, the hydrolysis of 
alginate takes place resulting in increased drug release 
at neutral pH. Unlike the acidic medium which did not 
provide any significant change in drug release (∼ 10% of 
GM loading) according to the preparative variables, in 
the neutral pH the burst effect became less relevant as 
the calcium concentration increased. Similarly to cross-
linked microparticles, the co-cross-linked microparticles 
showed a triphasic profile, having a reduced GM burst 
release in the neutral pH (30–40% of GM loading) with 
a slight effect offered by the polycationic concentration 
increase (Figure 6). However, the more strengthened 
microparticle structure provided by CS was not able to 
remove completely the burst effect in the neutral pH. At 
Spectrum 1
Spectrum 2
Spectrum 3
Spectrum 4
Spectrum 5
Spectrum 6
Mean
Spectrum Na Ca
3.51
0.13
0.80
1.93
0.42
0.45
96.49
99.87
99.20
98.07
99.58
99.55
1.21 98.79
SD 1.29 1.29
Min.
20µm
Spectrum 4
Spectrum 5
Spectrum 6
Spectrum 1
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Max. 3.51 99.87
Figure 3. EDX analysis coupled with SEM: relative sodium and calcium percentages calculated on element emission intensity from distinct 
microparticles. The image refers to the sample A1.
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this pH value, chitosan has less free amine groups due 
to the increased deprotonation providing a less strong 
interaction with alginate (Bajpai & Tankhiwale, 2006).
Microparticle bioadhesion and translocation studies
Microparticle capacity to adhere on the intestinal epithe-
lia and to be translocated across the intestinal epithelia 
was evaluated on the samples A1 and A1F selected from 
the pre-formulation study owing to their highest ability 
to retain the antibiotic as shown by the in vitro release 
assay. The sample A1F, compared with the sample A1, 
showed similar properties. Moreover, it was still fluores-
cent upon contact with simulated GI media, as observed 
by epifluorescence videomicroscopy (Figure 7).
The study involved an ex vivo method aiming to evalu-
ate the behavior of the microparticles at the level of both 
FAE containing M cells and mucosal epithelium contain-
ing enterocytes as well as an in vitro method aiming to 
evaluate the behavior of microparticles placed in contact 
with enterocyte-like cells.
Evaluation of microparticle bioadhesion and uptake 
by FAE
The study of microparticle bioadhesion and translocation 
across FAE containing M cells involved two small animal 
models represented by rabbits and rats having a different 
proportion of the FAE occupied by M cells, ∼ 50% and 
10%, respectively (Ermak et al., 1995). The identification 
of PP in intestinal tracts is a simple procedure since they 
can be seen by the naked eye as round thickened areas 
(Figure 8), located in the lamina propria of the mucosa 
and extending into the submucosa of the ileum.
The rabbit perfused intestinal tissue was examined by 
an interferential microscope for bioadhesion and trans-
location of the sample A1F and compared with untreated 
intestinal segments from the same rabbit. Unlike the 
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Figure 4. Antimicrobial activity of un-cross-linked (sample U), cross-
linked (sample A), and co-cross-linked (sample A1) microparticles.
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Figure 5. GM release from cross-linked microparticles in simulated 
gastrointestinal media.
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Figure 6. GM release from co-cross-linked microparticles compared 
with GM release from the sample A in simulated gastrointestinal 
media.
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Figure 7. Epifluorescence microscopy image of the sample A1F recov-
ered from simulated gastrointestinal media.
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untreated intestinal segments, the images of perfused 
segments showed dark dots, reasonably ascribable to 
the microparticles, on the epithelium exposed to the gut 
lumen at the level of PP or not-PP tissue (Figure 9a). This 
finding demonstrates the microparticle’s ability to adhere 
not only with the mucosal epithelium but also with rabbit 
FAE containing 50% M cells which are devoid of mucus. 
By viewing sections of the perfused intestinal segments, 
spheroidal structures were observed throughout the PP, 
mainly in the serosal side (Figure 9b). These structures, 
which are not attributable to cellular components and 
absent in both the untreated tissue and in perifollicular 
areas, could be reasonably identified with the micro-
particles translocated from the intestinal lumen into PP 
sub-epithelial regions.
The rat perfused intestinal tissue was examined by flu-
orescence microscope for bioadhesion and translocation 
of the sample A1F and compared with untreated intes-
tinal segments from the same rat. Unlike the untreated 
tissue, the perfused intestinal segments in correspond-
ence of both PP and non-PP epithelium showed a dotty 
fluorescence on the gut lumen surface (Figure 10a), 
reasonably attributable to the microparticles, confirming 
the polymer material ability to interact with both rat FAE 
and mucosal epithelium. By viewing perfused segment 
sections under fluorescence microscopy, a marked dotty 
fluorescence was observed inside both PP (Figure 10b) 
and non-PP tissue (villous epithelium) (Figure 10c). At 
the level of PP, the fluorescence was located in PP follicle 
germinal center and serosal side. Otherwise, at the level 
of non-PP tissue, the fluorescence was found only at the 
villus tips.
Therefore, microparticles showed their ability to be 
taken up by both FAE and mucosal epithelium. However, 
only the translocation across FAE provides microparti-
cle migration into deeper sub-epithelial regions. Such a 
behavior was not affected by the animal model, i.e. by the 
different M cell proportion in FAE. These results could 
cm
0 1 2
Figure 8. Image of a Peyer’s patch isolated from rat ileum.
A
B
Serosal side
Figure 9. Interferential microscopy images of intestinal segments, 
including PP and perifollicular areas, from rabbit after perfusion 
treatment with microparticles: gut lumen surface (a), Bouin’s-fixed 
gut sections (spheroidal structures identified with microparticles are 
circled) (b). Original magnification ×40.
A B C
Serosal side
Figure 10. Fluorescence microscopy images of intestinal segments from rat after perfusion treatment with microparticles: gut lumen surface (a), 
perfused segment in correspondence of a PP (b), perfused segment in correspondence of intestinal villi (c). Original magnification ×40.
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be attributed to the intense activity of sub-epithelial and 
intra-epithelial macrophages included in PP, as already 
observed by other authors for the transport of bacteria 
(Mamotani et al., 1988). On the contrary, a slight phago-
cytotic activity was referred for macrophages found at 
the lamina propria of the villus tips in some mammals 
(Iwanaga, 1995).
Microbiological analysis aiming to assay GM concen-
trations in rat perfused intestinal tracts containing two PP 
revealed an antibacterial activity corresponding to ∼ 15 
μg of GM. On the contrary, perfused intestinal segments 
non-containing PP as well as the untreated intestinal tis-
sue did not give evidence of microbial inhibition. This 
finding could be attributed to the more efficient or faster 
activity of PP in the transport of microparticles from 
the gut lumen to the serosal side compared with that of 
the intestinal regions without PP where microparticles 
appeared restricted to the epithelial regions, so providing 
low and undetectable GM concentrations.
The perfusion of microparticles suspended in pH 
7.4 phosphate buffer solution decreased the extent 
of antimicrobial activity (6.5 μg of GM) at the level of 
intestinal tract including PP. Since most microparticles 
disintegrated upon contact with a medium containing 
calcium chelating ions (Figure 11), the maintenance of 
the microparticulate structure would be essential to allow 
the transport across intestinal epithelia.
Evaluation of microparticle uptake by Caco-2 cells
The capacity of the sample A1F to interact with entero-
cytes was exploited by means of Caco-2 cell monolay-
ers. Such a technique represents the most commonly 
used cell line to study drug transport across enterocytes, 
offering the advantages of using an in vitro model as the 
initial stage of the research (Yee, 1997; Yamashita et al., 
2000; van der Lubben., 2002; Sambuy et al., 2005; Moyes 
et al., 2007). The interaction between the sample A1F and 
Caco-2 cells was evaluated by flow cytofluorimetry and 
showed by cell counts vs fluorescence intensity profiles. 
Caco-2 cells from control cultures showed a weak fluo-
rescence attributable to the natural fluorescence emis-
sion from cells. Following incubation at 37°C for 3 h, a 
pronounced shift to higher fluorescence intensity was 
observed, being the shift increased following 6 h incuba-
tion (Figure 12a). Reducing the temperature to 4°C, cells 
did not produce significant fluorescence above control 
cultures (Figure 12b). Confocal microscopy analysis 
provided a superimposed montage of 10 confocal optical 
sections of a Caco-2 cell monolayer, having blue stained 
nuclei, after 6 h of incubation at 37°C with the sample A1F 
in comparison with the control, both observed under 
filter set for green and blue fluorescence (Figure 13). 
Caco-2 cells treated with the sample A1F revealed the 
presence of strong green fluorescence spots (Figure 13c), 
with diameters corresponding to the microparticle 
size, around the respective nuclei (Figure 13d). On the 
contrary, control Caco-2 cells as well as Caco-2 cells 
incubated with FITC solutions showed a very weak and 
diffuse fluorescence (Figure 13a) around the respective 
nuclei (Figure 13b). The green spots observed in Caco-2 
cells treated with the sample A1F suggest reasonably the 
presence of microparticles inside the cytoplasm and, 
then, the occurring of an internalization process at 37°C. 
10 µm
Figure 11. SEM image of the sample A1 after 30 min contact with pH 
7.4 phosphate buffer solution.
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Figure 12. Cytofluorimetric analysis at 37°C (A) and 4°C (B): control 
(a), 3 h incubation (b), 6 h incubation (c).
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The result obtained by using Caco-2 cell lines is consist-
ent with those reported by other authors showing, in 
general, an intracellular localization for microparticles 
sized from 0.5–2 μm, with the exclusion for particles > 4 
μm (McClean et al., 1998).
Conclusions
Gentamicin-loaded alginate/chitosan microparticles 
have been investigated as an oral drug delivery system. 
The study performed on ex vivo animal models demon-
strated the microparticle bioadhesiveness at the level 
of both mucosal epithelium and FAE encasing Peyer’s 
patches and their ability to be endocytosed by both epi-
thelial cells, as confirmed by the in vitro model (Caco-2 
cell lines). However, microparticles appeared to be deliv-
ered into sub-epithelial regions only in correspondence 
of the lymphoid aggregates, regardless of the animal 
model used and, consequently, the proportion of M cells 
in FAE. Therefore, a more efficient microparticle translo-
cation process by M cells compared with that by entero-
cytes could be supposed even if the entire microparticle 
pathway toward blood circulation should be examined in 
vivo to demonstrate the possible drug therapeutic effect. 
Furthermore, the study demonstrated the usefulness 
of both ex vivo and in vitro models in the preliminary 
assessment of microparticulate matter transport across 
the intestinal epithelia.
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